Field map-based rectification of susceptibility distortion and signal compensation in diffusion tensor imaging

目的采用基于体素的场图对磁共振弥散张量成像(diffusion-tensor; imaging,DTI)进行几何变形矫正及信号补偿研究,扩大DTI临床研究及应用价值。材料与方法获取29名健康人脑场图,分别对其DTI进行相位反; 卷积计算及信号校准补偿,将结果配准到3D结构图像。选择对磁场敏感的双侧颅底额叶和颞叶作为观察脑区,对磁场不敏感的丘脑作为对照脑区,对部分各向异性; (fractional; anisotropy,FA)值及信号的差异及其与结构像的形态差异进行统计分析。结果在颅底额叶和颞叶,DTI的磁敏感变形得到了矫正,因场不均性导致; 的信号损失得到了补偿。结论高场中DTI的畸变及体素信号丢失可应用场图的校准得到明显矫正,有利于进一步扩大高场DTI在临床中的应用价值。Objective: This study was designed to employ the voxel-based field map; to rectify the geometric deformation and compensate the signal loss of; diffusion tensor imaging (DTI), and thus facilitate the studies and; clinical applications of DTI. Materials and Methods: Brain field maps; from 29 healthy persons were first used to get B1 field heterogeneous; signals, and then the compensation and phase disconsolation of signals; were performed. Finally, the geometry deformations of DTI were rectified; and registered to 3D images. Magnetic sensitive bilateral temporal lobes; and frontal lobes were selected as regions of interesting and meanwhile,; magnetic insensitive thalamus was selected as control area. Results:; Geometry deformations of DTI produced by different susceptibilities; between specific tissues were completely rectified, and thus the signal; loss was compensated and the accuracy of DTI was significantly enhanced.; Conclusion: Signal compensations and deformation rectifications can be; well achieved using field map, which may improve the applications of DTI; in neurosurgery.国家自然科学基金面上项

颅内原发恶性淋巴瘤的MRI诊断(附12例报告)

目的　探讨颅内原发恶性淋巴瘤CT及MR的表现特征 ,以提高诊断准确率。方法　对 12例经手术病理证实的颅内原发恶性淋巴瘤的CT及MR表现进行回顾分析。结果　共检出 3 2个病灶 ,其中单发 9例 ,分别位于额、颞、顶叶深部脑白质 8例 ,位于颞叶表面 1例 ;多发 3例 ,病灶多位于深部脑白质。CT多表现为圆形或类圆形稍高密度灶 ,MRI表现为T1WI低或等信号 ,T2 WI为稍低信号。多数病灶周围有轻 -中度高信号水肿带 ,病灶边界尚清楚。增强扫描见所有病灶均有强化 ,2 3个 ( 72 .0 % )病灶呈均匀强化 ,18个 ( 5 6.2 5 % )病灶强化后出现缺口或凹陷改变。病理结果 :11例为非何杰金氏淋巴瘤 ,1例为浆细胞淋巴瘤。结论　尽管颅内原发恶性淋巴瘤的影像表现与其它颅内肿瘤如脑膜瘤、胶质瘤及转移瘤等有许多相似之处 ,但通过认真分析其影像特征 ,术前的正确诊断是有可能

脑型肝豆状核变性脑皮层及皮层下核团体积的磁共振研究

目的探索脑型肝豆状核变性患者脑灰质的损害。材料与方法采集30例初发且未经治疗的脑型肝豆状核变性患者脑3D T1WI图像,利用FSL软件,运用基于体素的形态学测量(voxel_based morphometry,VBM)对脑皮层...国家自然科学基金项目(编号:81671674、81871519)~

The morphological study of brain cortical in chronic obstructive pulmonary disease

目的研究应用基于体素的形态学分析(VbM)方法,观察慢性梗阻性肺部病变(COPd)患者的大脑皮质变化。材料与方法搜集在住院中的COPd患者(患者组)25例和年龄、性别、文化背景等相似的志愿者(对照组)25例进行肺功能、精神状态检查及血气分析。二组均行3d T1WI检查,采用VbM、fSl分析软件(簇体积减少>70体素)。应用一般线性模型进行统计学分析,计算两组的全脑灰质总体积,基于体素比较两组全脑灰质各个体素体积的差异。结果COPd患者日常生活活动性、简易精神状态测试、视觉重建及数字记忆测试预测值明显低于正常人。患者额叶的双侧眶回、双侧额下回三角区(brOCA区),以及双额内側回、右侧前岛回及深部核团等局部灰质体积较正常对照组减少(P值均70 voxel).Statistical analysis was performed using the general linear model to detect whole brain gray matter volume differences between the two groups.Results: Compared with the control group, the patients with COPD had markedly lower scores in the activities of daily life, the Mini-Mental State Examination, and Visual Reproduction, and Figure Memory tests.Statistical correlation between two groups showed significant gray matter volume loss in the regions of frontal lobe(bilateral orbital gyros, bilateral inferior frontal gyrus triangle), medial frontal gyrus, right anterior insular gyrus, and deep nuclei(P<0.01).According to the statistics of t value maximum voxels in coordinate of MNI, the Brodmann regions of the brain, which obviously atrophy, were mainly in 47 brain regions(superior frontal gyrus), the bilateral 13 brain regions(insular cortex), 22 brain regions(superior temporal gyrus), bilateral 32 and 24 brain regions.Conclusions: In COPD patients, the cortex volume of multiple brain areas can reduce, the damage regions mainly relate to bilateral prefrontal cortex, medial frontal gyrus, and right anterior insular gyrus.The regions of brain cortex injury are consistent with other diseases, such as obstructive sleep apnea, congenital central expiratory deficiency syndrome, and the cerebral injury of people living in high altitude areas.国家自然科学基金面上项目(编号:31071041

The primary investigation of the value of whole body diffusion weighted imaging in diagnosis of metastatic tumor

背景与目的:随着临床上晚期肿瘤病例的增多,为了解治疗前、后全身转移瘤的大小及数量变化的实际情况,以往多采用分部位进行CT和(或)Mr扫描,少部分有条件的患者采用PET检查,但这些方法可能存在过多地暴露于射线、检查时间过长及经济负担过重等问题。因此,我们探讨磁共振的全身弥散加权成像(WHOlE bOdy dIffuSIOn WEIgHTEd IMAgIng,WbdWI)方法对肿瘤及转移灶的检出准确性及其临床应用的可行性。方法:对68例临床已发现原发肿瘤及多个转移灶或发现多个肿瘤病灶,但原发灶不明确的患者进行WbdWI检查,其中男性49例;女性19例。平均年龄61岁。68例均与CT和(或)MrI的检查结果进行比较,其中17例与PET的检查结果相比较。对病灶的检出率,以病灶长径大小分为:<1CM,≥1~<2CM,≥2~<3CM及≥3CM以上4组进行计数分析,同时,对不同部位间的病灶检出情况进行分析。结果:WbdWI对4组病灶的检出率分别为30%、78%、96%及100%。在各个部位的敏感性和准确性中以骨骼最高。对位于肺部小于1CM的病灶和位于颈部、盆腔小于2CM的淋巴结的诊断存在一定困难。结论:WbdWI对大范围的肿瘤病灶筛查是安全、简便、有效和经济的检查新方法。随着技术参数的进一步完善,WbdWI在发现和诊断全身多发肿瘤方面,具有良好的发展潜力。因此,本技术有望作为一种新的、效果好于PET的全身检查技术。Background and purpose:With the increased number of advanced tumors,it is important to evaluate the actual pre-and post-treatment changes in metastatic diseases,such as tumor size and tumor quantity.Previously,CT and/or MRI scan were usually applied,only a few patients could pay for PET(positron emition tomography).But there were several problems we should face,including redundantly exposure to radiation,too long verification time and heavy financial burden.Therefore we evaluated the application of whole body diffusion weighted imaging in diagnosing of tumor and metastatic tumor.Methods:sixty-eight patients(49 male,19 female,age from 29 to 84 years with mean age of 61 years) with a variety of tumors were investigated by combined CT and/or MRI scan,seventeen patients were compared with positron emition tomograph(PET).All tumors were classified into four groups,according to longest diameter of <1 cm,≥1-<2 cm,≥2-<3 cm and ≥3 cm.At the same time,the positive detection rates between different parts of the lesions were analyzed.Results:The detection rate of the four groups were 30%,78%,96% and 100%,respectively.The skeletal system had the highest sensitivity and accuracy in every part of body.There was difficulty in diagnosing lung cancer with longest diameter less than 1 cm as well as tumors located in neck and pelvic with longest diameter less than 2 cm.Conclusion:Whole body diffusion weighted imaging is secure,convenient,effective and economic for screening wide-ranging tumor focus.After improvement of parameters,WBDWI could be as a new effective whole body examination technique.厦门市科技计划项目(No:3502Z20074017

Adaptive Modulation of Adult Brain Gray and White Matter to High Altitude: Structural MRI Studies

National Science Foundation of China [31071041, 81171324]; National Key project [2012CB518200]The aim of this study was to investigate brain structural alterations in adult immigrants who adapted to high altitude (HA). Voxel-based morphometry analysis of gray matter (GM) volumes, surface-based analysis of cortical thickness, and Tract-Based Spatial Statistics analysis of white matter fractional anisotropy (FA) based on MRI images were conducted on 16 adults (20-22 years) who immigrated to the Qinghai-Tibet Plateau (2300-4400 m) for 2 years. They had no chronic mountain sickness. Control group consisted of 16 matched sea level subjects. A battery of neuropsychological tests was also conducted. HA immigrants showed significantly decreased GM volumes in the right postcentral gyrus and right superior frontal gyrus, and increased GM volumes in the right middle frontal gyrus, right parahippocampal gyrus, right inferior and middle temporal gyri, bilateral inferior ventral pons, and right cerebellum crus1. While there was some divergence in the left hemisphere, surface-based patterns of GM changes in the right hemisphere resembled those seen for VBM analysis. FA changes were observed in multiple WM tracts. HA immigrants showed significant impairment in pulmonary function, increase in reaction time, and deficit in mental rotation. Parahippocampal and middle frontal GM volumes correlated with vital capacity. Superior frontal GM volume correlated with mental rotation and postcentral GM correlated with reaction time. Paracentral lobule and frontal FA correlated with mental rotation reaction time. There might be structural modifications occurred in the adult immigrants during adaptation to HA. The changes in GM may be related to impaired respiratory function and psychological deficits

Compromised White Matter Microstructural Integrity after Mountain Climbing: Evidence from Diffusion Tensor Imaging

National Science Foundation of China [31071041]Zhang, Haiyan, Jianzhong Lin, Yingchun Sun, Yongxia Huang, Huiming Ye, Xiaochuan Wang, Tianhe Yang, Xingtang Jiang, Jiaxing Zhang. Compromised white matter microstructural integrity after mountain climbing: Evidence from diffusion tensor imaging. High Alt. Med. Biol. 13: 118-125.-The aim of the present study was to investigate cerebral microstructural alterations after single short-term mountain climbing. Voxel-based morphometry (VBM) analysis of gray matter (GM) and white matter (WM) volumes and Tract-Based Spatial Statistics (TBSS) analysis of WM fractional anisotropy (FA) based on MRI images were carried out on 14 mountaineers before and after mountain climbing (6206 m). In addition, verbal and spatial 'two-back' tasks and serial reaction time task were also tested. No significant changes were detected in total and regional volumes of GM, WM, and cerebral spinal fluid after mountain climbing. Significant decreased FA values were found in the bilateral corticospinal tract, corpus callosum (anterior and posterior body, splenium), reticular formation of dorsal midbrain, left superior longitudinal fasciculus, right posterior cingulum bundles, and left middle cerebellar peduncle. In all the above regions, the radial diffusivity values tended to increase, except in the left superior longitudinal fasciculus the change was statistically significant. There were no significant changes in the two cognitive tests after mountain climbing. These findings indicate that short-term high-altitude exposure leads to disturbances mainly in cerebral WM, showing compromised fiber microstructural integrity, which may clarify the mechanisms underlining some cognitive and motor deficits tested previously

中国高等植物受威胁物种名录

2008年,环境保护部和中国科学院联合启动了《中国生物多样性红色名录——高等植物卷》的编制工作。通过这项工作,我们依据IUCN濒危物种红色名录标准对中国野生高等植物的濒危状况进行了全面评估,编制了中国高等植物红色名录。2013年9月,该名录以环境保护部、中国科学院第54号公告形式发布,即《中国生物多样性红色名录—

Aripiprazole versus other atypical antipsychotics for schizophrenia

BACKGROUND: In most western industrialised countries, second generation (atypical) antipsychotics are recommended as first line drug treatments for people with schizophrenia. In this review we specifically examine how the efficacy and tolerability of one such agent - aripiprazole - differs from that of other comparable second generation antipsychotics. OBJECTIVES: To evaluate the effects of aripiprazole compared with other atypical antipsychotics for people with schizophrenia and schizophrenia-like psychoses. SEARCH METHODS: We searched the Cochrane Schizophrenia Group Trials Register (November 2011), inspected references of all identified studies for further trials, and contacted relevant pharmaceutical companies, drug approval agencies and authors of trials for additional information. SELECTION CRITERIA: We included all randomised clinical trials (RCTs) comparing aripiprazole (oral) with oral and parenteral forms of amisulpride, clozapine, olanzapine, quetiapine, risperidone, sertindole, ziprasidone or zotepine for people with schizophrenia or schizophrenia-like psychoses. DATA COLLECTION AND ANALYSIS: We extracted data independently. For dichotomous data we calculated risk ratios (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis based on a random-effects model. Where possible, we calculated illustrative comparative risks for primary outcomes. For continuous data, we calculated mean differences (MD), again based on a random-effects model. We assessed risk of bias for each included study. MAIN RESULTS: We included 12 trials involving 6389 patients. Aripiprazole was compared to olanzapine, risperidone and ziprasidone. All trials were sponsored by an interested drug manufacturer. The overall number of participants leaving studies early was 30% to 40%, limiting validity (no differences between groups).When compared with olanzapine no differences were apparent for global state (no clinically important change: n = 703, 1 RCT, RR short-term 1.00 95% CI 0.81 to 1.22; n = 317, 1 RCT, RR medium-term 1.08 95% CI 0.95 to 1.22) but mental state tended to favour olanzapine (n = 1360, 3 RCTs, MD total Positive and Negative Syndrome Scale (PANSS) 4.68 95% CI 2.21 to 7.16). There was no significant difference in extrapyramidal symptoms (n = 529, 2 RCTs, RR 0.99 95% CI 0.62 to 1.59) but fewer in the aripiprazole group had increased cholesterol levels (n = 223, 1 RCT, RR 0.32 95% CI 0.19 to 0.54) or weight gain of 7% or more of total body weight (n = 1095, 3 RCTs, RR 0.39 95% CI 0.28 to 0.54).When compared with risperidone, aripiprazole showed no advantage in terms of global state (n = 384, 2 RCTs, RR no important improvement 1.14 95% CI 0.81 to 1.60) or mental state (n = 372, 2 RCTs, MD total PANSS 1.50 95% CI -2.96 to 5.96).One study compared aripiprazole with ziprasidone (n = 247) and both the groups reported similar change in the global state (n = 247, 1 RCT, MD average change in Clinical Global Impression-Severity (CGI-S) score -0.03 95% CI -0.28 to 0.22) and mental state (n = 247, 1 RCT, MD change PANSS -3.00 95% CI -7.29 to 1.29).When compared with any one of several new generation antipsychotic drugs the aripiprazole group showed improvement in global state in energy (n = 523, 1 RCT, RR 0.69 95% CI 0.56 to 0.84), mood (n = 523, 1 RCT, RR 0.77 95% CI 0.65 to 0.92), negative symptoms (n = 523, 1 RCT, RR 0.82 95% CI 0.68 to 0.99), somnolence (n = 523, 1 RCT, RR 0.80 95% CI 0.69 to 0.93) and weight gain (n = 523, 1 RCT, RR 0.84 95% CI 0.76 to 0.94). Significantly more people given aripiprazole reported symptoms of nausea (n = 2881, 3 RCTs, RR 3.13 95% CI 2.12 to 4.61) but weight gain (7% or more of total body weight) was less common in people allocated aripiprazole (n = 330, 1 RCT, RR 0.35 95% CI 0.19 to 0.64). Aripiprazole may have value in aggression but data are limited. This will be the focus of another review. AUTHORS' CONCLUSIONS: Information on all comparisons are of limited quality, are incomplete and problematic to apply clinically. Aripiprazole is an antipsychotic drug with a variant but not absent adverse effect profile. Long-term data are sparse and there is considerable scope for another update of this review as new data emerges from the many Chinese studies as well as from ongoing larger, independent pragmatic trials